Search the Video Library

Filter by Date

Video Language

Filter by Cancer Type:

-- Immunotherapy for NSCLC (51)

    Displaying Results 61 - 75 of 134

    Lung Cancer Video Library - Immunotherapy for Previously Treated Patients with NSCLC

    Dr. Karen Reckamp, MD, MS, City of Hope Comprehensive Cancer Center in Duarte, California joined GRACE to discuss the role of immunotherapy for previously treated patients with non-small cell lung cancer.

    Lung Cancer Video Library - Spanish Language: PDL1 as a biomarker for second line treatment

    In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for second-line treatment.

    Lung Cancer Video Library - Spanish Language: PDL1 as a biomarker for first line treatment

    In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for first-line treatment.

    Lung Cancer Video Library - Spanish Language: Combinations of first-line treatment, immunotherapy agents combined

    In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy combined.

    Lung Cancer Video Library - Spanish Language: Combinations of first-line treatment, immunotherapy with chemotherapy

    Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy with chemotherapy.

    Lung Cancer Video Library 2017 - The Role for Immunotherapy in Patients with a Driver Mutation

    Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses the role for immunotherapy in patients with a driver mutation.

    Lung Cancer Video Library - 2017 Should Immunotherapy be Stopped in a Fixed Duration of Treatment?Responding Patients After

    Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses if immunotherapy should stop in responding patients after a fixed duration of treatment.

    Lung Cancer Video Library - 2017 Changing Standard of Care for Stage 3 Non-Small Cell Lung Cancer (NSCLC)

    Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses the changing standard of care for stage 3 non-small cell lung cancer (NSCLC).

    Lung Cancer Video Library - Is There A Role For PD-L1 Testing After First Line Treatment For Advanced Non-Small Cell Lung Cancer (NSCLC) In Those Previously Untested
    Immunotherapy

    Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses if there is a role for PD-L1 testing after first line treatment.

    Lung Cancer Video Library - Continuing Immunotherapy Beyond Progression In Which Patients Is This Appropriate

    Stephen Liu, MD provides updates to our Lung Cancer Video Library. In this recent video, Dr. Liu discusses Continuing Immunotherapy Beyond Progression-In Which Patients Is This Appropriate

    Lung Cancer Video Library - BRAF V600E As A Target In Advanced Non-Small Cell Lung Cancer

    Stephen Liu, MD provides updates to our Lung Cancer Video Library. In this recent video, Dr. Liu discusses BRAF V600E As A Target In Advanced Non-Small Cell Lung Cancer

    Lung Cancer Video Library - Timing Of Discussion Of Maintenance Therapy In First Line Treatment for Lung Cancer
    Lung Cancer Video Library

    We are pleased to have GRACE’s Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute in Seattle, Washington, and President and CEO of GRACE bring 2017 updates to our Lung Cancer Video Library. In this latest video, Dr. West discusses advances in NSCLC – Timing Of

    Lung Cancer Video Library - PDL1 as a Biomarker for Second Line
    Lung Cancer Video Library

    Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses PDL1 as a biomarker for second line.

    Lung Cancer Video Library - PDL1 As A Biomarker For First Line

    Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses PDL1 as a biomarker for first line.

    ASCO 2017 - Lung Cancer - Continuing Immunotherapy Beyond Progression

    Drs. H. Jack West, Matthew Gubens, and Jyoti Patel, gathered post ASCO 2017 to discuss new information regarding lung cancer. In this video, the doctors discuss Continuing Immunotherapy Beyond Progression.